Blair William & Co
- SEC CIK
- 0000902367
- Latest filing
- Aug 11, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by Blair William & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −104,211−100.0% | Sold out | Holders |
| Q2 2025 | 104,211 | $255.3K | <0.1% | −7,264−6.5% | Reduced | Holders |
| Q1 2025 | 111,475 | $743.5K | <0.1% | −4,563−3.9% | Reduced | Holders |
| Q4 2024 | 116,038 | $1.46M | <0.1% | −18,931−14.0% | Reduced | Holders |
| Q3 2024 | 134,969 | $2.49M | <0.1% | −7,745−5.4% | Reduced | Holders |
| Q2 2024 | 142,714 | $3.07M | <0.1% | −4,566−3.1% | Reduced | Holders |
| Q1 2024 | 147,280 | $3.97M | <0.1% | +401+0.3% | Added | Holders |
| Q4 2023 | 146,879 | $4.40M | <0.1% | −2,910−1.9% | Reduced | Holders |
| Q3 2023 | 149,789 | $3.07M | <0.1% | +149,789 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −11,431−100.0% | Sold out | Holders |
| Q3 2022 | 11,431 | $182.0K | <0.1% | −1,300−10.2% | Reduced | Holders |
| Q2 2022 | 12,731 | $175.0K | <0.1% | +180+1.4% | Added | Holders |
| Q1 2022 | 12,551 | $199.0K | <0.1% | +400+3.3% | Added | Holders |
| Q4 2021 | 12,151 | $265.0K | <0.1% | −100−0.8% | Reduced | Holders |
| Q3 2021 | 12,251 | $366.0K | <0.1% | −350−2.8% | Reduced | Holders |
| Q2 2021 | 12,601 | $558.0K | <0.1% | −1,905−13.1% | Reduced | Holders |
| Q1 2021 | 14,506 | $644.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.